Drug donanemab seen as turning point in dementia fight

The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.

Related Keywords

London ,City Of ,United Kingdom ,Michelle Roberts ,Emer Macsweeney ,Susan Kohlhaas ,Fergus Walsh ,Kate Lee ,Eli Lilly ,Giles Hardingham ,Mike Colley ,Cognition Health ,United Kingdom Dementia Research Institute ,Alzheimer Society ,Alzheimer Research United Kingdom ,Research United Kingdom ,